The in situ local immune response, tumour senescence and proliferation in colorectal cancer

被引:24
|
作者
Roxburgh, C. S. [1 ]
Richards, C. H. [1 ]
MacDonald, A. I. [2 ]
Powell, A. G. [1 ]
McGlynn, L. M. [2 ]
McMillan, D. C. [1 ]
Horgan, P. G. [1 ]
Edwards, J. [3 ]
Shiels, P. G. [2 ]
机构
[1] Univ Glasgow, Royal Infirm, Acad Unit Surg, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Unit Epigenet, Glasgow, Lanark, Scotland
[3] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Unit Expt Therapeut, Glasgow, Lanark, Scotland
关键词
immune cells; senescence; proliferation; colorectal cancer; p16(ink4a); CDKN2A; CELLULAR SENESCENCE; INFILTRATING LYMPHOCYTES; INFLAMMATORY RESPONSE; PROGNOSTIC-FACTOR; BREAST-CANCER; T-CELLS; SURVIVAL; EXPRESSION; P16; METASTASIS;
D O I
10.1038/bjc.2013.556
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Immune cell infiltrates are important determinants of colorectal cancer (CRC) outcome. Their presence may be driven by tumour or host-specific factors. From previous studies in mice, senescence, a state of cell cycle arrest, may moderate tumour progression through upregulation of antitumour immune responses. The relationships between senescence and immune infiltrates have not previously been studied in humans. We explore whether a marker of senescence (p16(ink4a)) in combination with low level expression of a proliferation marker (ki-67) relate to T cell infiltrates in CRC, and whether p16(ink4a), Ki-67 and immune infiltrates have similar prognostic value. Methods: Immunostaining of p16(inka) and Ki-67 was performed within a CRC tissue microarray. Nuclear p16(inka) and Ki-67 were categorised as high/low. T-cell markers, CD3, CD45RO, CD8 and FOXP3 were scored separately as high/low grade in three areas of the tumour: the invasive margin (IM), tumour stroma and cancer cell nests (CCNs). Results: Two hundred and thirty stage I-III cancers were studied. High nuclear p16(ink4a) was expressed in 63% and high proliferation (Ki-67 > 15%) in 61%. p16(ink4a) expression was associated with reduced CD45RO + cells at the IM (P<0.05) and within the stroma (P<0.05) and reduced CD8+ cells at the IM (P<0.01). A low Ki-67 proliferative index was associated with reduced density of CD3+ cells in CCNs (P<0.01), reduced CD45RO+ cells at the IM (P<0.05) and within the CCNs (P<0.001), reduced FOXP3+ cells at the IM (P<0.001), within the stroma (P=0.001) and within CCNs (P<0.001) and reduced CD8+ cells at the IM (P<0.05) and within the CCNs (P<0.05). Tumours with both a low proliferative index and expression of p16(ink4a) demonstrated similar consistent relationships with reduced densities of T-cell infiltrates. On multivariate analysis, TNM stage (P<0.001), low CD3 cells at the IM (P=0.014), low CD8 cells at the IM (P=0.037), low proliferation (Ki-67; P=0.013) and low senescence (p16(ink4a); P=0.002) were independently associated with poorer cancer survival. Conclusion: Senescence, proliferation and immune cell infiltrates are independent prognostic factors in CRC. Although related to survival, p16(ink4a)-associated senescence is not associated with an upregulation of antitumour T-cell responses.
引用
收藏
页码:2207 / 2216
页数:10
相关论文
共 50 条
  • [31] INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer
    Chen, Shuai
    Gong, Yu
    Shen, Yu
    Liu, Yu
    Fu, Yue
    Dai, Yi
    Rehman, Adeel Ur
    Tang, Liming
    Liu, Hanyang
    JOURNAL OF CANCER, 2021, 12 (19): : 5938 - 5949
  • [32] Proliferation of T-cell subsets that contact tumour cells in colorectal cancer
    Golby, SJC
    Chinyama, C
    Spencer, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01): : 85 - 91
  • [33] The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
    Roxburgh, C. S. D.
    McMillan, D. C.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 451 - 466
  • [34] Colorectal cancer: immune response in laparoscopic versus open colorectal surgery
    Martinez-Martinez, Ana B.
    Arbones-Mainar, Jose M.
    CIRUGIA Y CIRUJANOS, 2022, 90 (03): : 295 - 302
  • [35] Cellular senescence and colorectal cancer
    Foersch, S.
    PATHOLOGE, 2017, 38 : S205 - S210
  • [36] LOCAL IMMUNE-RESPONSE TO HUMAN CANCER
    PELLETIER, G
    PELOUZE, G
    BONENFANT, JL
    UNION MEDICALE DU CANADA, 1979, 108 (04): : 440 - 441
  • [37] LncRNA MIAT Promotes the Proliferation and Invasion of Colorectal Cancer via Suppressing Apoptosis and Senescence
    Amirmahani, Farzane
    Asadi, Malek Hossein
    Alipoor, Firooz Jannat
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (02) : 219 - 229
  • [38] Cytokines are a novel target for therapy to reduce local recurrence and manipulate the immune response in human colorectal cancer
    Bailey, C
    Negus, R
    Alkhamesi, N
    Brinkman, H
    Goldin, R
    Peck, D
    Darzi, A
    BRITISH JOURNAL OF SURGERY, 2004, 91 (09) : 1231 - 1232
  • [39] Effects of senescence on the tumour microenvironment and response to therapy
    Reynolds, Louise E.
    Maallin, Seynab
    Haston, Scott
    Martinez-Barbera, Juan Pedro
    Hodivala-Dilke, Kairbaan M.
    Pedrosa, Ana-Rita
    FEBS JOURNAL, 2023, : 2306 - 2319
  • [40] Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer
    Lowenmark, Thyra
    Li, Xingru
    Lofgren-Burstrom, Anna
    Zingmark, Carl
    Ling, Agnes
    Kellgren, Therese G.
    Larsson, Par
    Ljuslinder, Ingrid
    Wai, Sun Nyunt
    Edin, Sofia
    Palmqvist, Richard
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (10) : 2565 - 2575